Grifols prepares for late-stage plans with plasma-derived medicines in 2024 - Pharmaceutical Technology (2024)

FAQs

Grifols prepares for late-stage plans with plasma-derived medicines in 2024 - Pharmaceutical Technology? ›

Grifols plans to release Phase III results of its long-term albumin treatment designed to increase survival time in patients with decompensated cirrhosis and ascites in 2024, says chief scientific innovations officer Jörg Schüttrumpf.

Main products

Grifols is the major world supplier of IVIG, albumin, Factor VIII and other plasma-derived products.

Plasma-derived therapies are critical, life-saving medicines that thousands of people with rare and complex diseases rely on every day around the world. Global demand for these therapies, particularly immunoglobulins, has increased dramatically over the last 15 years, and continues to grow.

We make plasma medicines that treat people with chronic, rare and sometimes very serious diseases.

With a workforce of over 23,000 employees in more than 30 countries and regions, we are committed to a sustainable business model that sets the standard for continuous innovation, quality, safety and ethical leadership in the industry.

How much does Grifols pay for plasma? On average, Grifols donors can earn about $400 a month by donating plasma the maximum number of times over a 30-day period. Each Grifols donate plasma center has its own unique compensation structure.

The short seller accused Grifols of manipulating its debt-to-earnings figures by consolidating earnings of units it doesn't control, meaning leverage was likely double reported levels, and said shares were “uninvestible.” The Spanish company rejected Gotham City's research as “false information and speculations.”

BioLife Plasma Services is among the top payers in the plasma donation industry. New donors at BioLife can earn up to $900 in their first month through various promotions and bonuses. This high payout is broken down into specific bonuses for each of the initial donations.

Is Grifols plasma legit? ›

All Grifols plasma centers are licensed and regulated by the FDA and other international agencies.

Biomat USA's exact donor compensation varies by location, but it generally pays $150 to $300 per month for regular plasma donations. You'll earn somewhere between $40 and $75 for each donation.

Nacho Abia (Apr 1, 2024–)

Grifols / CEO

Barcelona, Spain

Grifols / Headquarters

Grifols has a market cap or net worth of $6.69 billion as of July 16, 2024. Its market cap has increased by 7.59% in one year.

Albumin Grifols 20% Infusion is used to treat blood volume loss. It works by replacing the body fluids lost due to excessive trauma, bleeding, surgery, or kidney dialysis. Thus, it is helpful in treating low blood albumin levels.

This state-of-the-art method tests for DNA particles of viruses. Each donation undergoes a serological test that looks for antibodies that the body produces in response to a virus. These screening tests are performed at Grifols laboratories and are not considered a formal medical diagnosis.

Since early January, short-sheller fund Gotham City Research has released several reports accusing Grifols of overstating earnings and understating debt. Grifols' market value has shed several billion euros since then.

Caring for people. Grifols, we are people helping people.